Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.
Eris Biotech has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2024.
Eris Biotech's investors include Y Combinator.
Eris Biotech is headquartered in American Fork, United States.
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors.
Eris Biotech is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eris Biotech — Funding & Investors." VCBacked, February 8, 2024, https://www.vcbacked.co/company/eris-biotech. Accessed August 17, 2026.
VCBacked. (2024). Eris Biotech — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/eris-biotech
{{cite web |title=Eris Biotech — Funding & Investors |url=https://www.vcbacked.co/company/eris-biotech |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated